Jennifer Schranz Net Worth & Insider Trades
Jennifer Schranz - Chief Medical Officer, Nabriva Therapeutics Plc
What is Jennifer Schranz's Net Worth?
The current estimated net worth of Nabriva Therapeutics Plc's Chief Medical Officer, Jennifer Schranz, is estimated to be about $82.17K . Jennifer Schranz owns about 5,500 units of Nabriva Therapeutics Plc common stock. In the last 3 years at Nabriva Therapeutics Plc, Jennifer Schranz has sold an estimated value of $8.19K worth.
What is Jennifer Schranz's Past Insider Trading?
Jennifer Schranz's largest purchase order was 5,500 units , worth over $20.52K on June 25, 2018. In total, Jennifer Schranz has made about 18 transactions over 3 years of their time at Nabriva Therapeutics Plc. Jennifer Schranz usually trades in February, with the busiest year in 2020.
Jennifer Schranz
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Jennifer Schranz's Salary in 2020?
As Chief Medical Officer of Nabriva Therapeutics Plc, Jennifer Schranz has a total base salary of $460,000 . Jennifer Schranz received compensation valued at about $1,074,113 in 2020 after becoming Chief Medical Officer. The vast majority of their compensation came in the form of a bonus of $100,000 , other earnings, plans or compensations of $145,203 , option awards of $156,818 , other earnings, plans or compensations of $145,203 , and other compensation of $28,604 .
What is Jennifer Schranz's' Mailing Address?
- Mailing address is 1000 Continental Drive Suite 600 King of Prussia PA 19406 PA
Nabriva Therapeutics Plc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Other Earnings Plans or Compensations
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Theodore Schroeder | 2020 | $576,800 | - | $242,256 | $339,625 | $242,256 | $31,759 | $1,654,570 |
| Theodore Schroeder | 2019 | $560,000 | - | $119,250 | $478,367 | $119,250 | $28,372 | $1,496,164 |
| Steven Gelone | 2020 | $486,300 | - | $153,185 | $231,493 | $153,185 | $12,675 | $1,154,516 |
| Steven Gelone | 2019 | $472,100 | - | $181,420 | $309,859 | $181,420 | $13,976 | $1,178,280 |
| Jennifer Schranz | 2020 | $460,000 | $100,000 | $145,203 | $156,818 | $145,203 | $28,604 | $1,074,113 |
| Jennifer Schranz | 2019 | $436,200 | - | $151,200 | $261,555 | $151,200 | $33,450 | $982,155 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1641640/000110465921088033/tm2119969-2_def14a.htm
What are Nabriva Therapeutics Plc's Past Insider Trades?
Nabriva Therapeutics Plc's most recent insider trade came on August 4, 2022 by Daniel Burgess who sold 11,341 units worth $2.16K . In the last 5 years, insiders at Nabriva Therapeutics Plc have sold an estimated value of $5.26M and bought an estimated value of $1.22M worth of shares. Insider trading is most common in August, with the busiest year in 2021. The most active traders at the company are Steven Gelone, Director, Theodore Schroeder, Director, and Robert Crotty, Gen Counsel & Corp Secretary .
Nabriva Therapeutics Legacy plc Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||